Skip to Main Content

Paper Details

Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry.
Acta Ophthalmol
5
2022
Author NameAffiliation
Vuong NguyenSave Sight Institute, Sydney Medical School, The University of Sydney
Javier Zarranz-VenturaClinical Institute of Ophthalmology (ICOF), Hospital Clinic
Javier Zarranz-VenturaAugust Pi i Sunyer Biomedical Research Institute (IDIBAPS)
Mark C GilliesSave Sight Institute, Sydney Medical School, The University of Sydney
Daniel BarthelmesSave Sight Institute, Sydney Medical School, The University of Sydney
Daniel BarthelmesUniversity Hospital Zurich, University of Zurich
  • 1 - 6

Datasets

Release 1.2